← Leaderboards
Zongbing You
Tulane University Of Louisiana
$2,097,503
Attributed
$2,097,503
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $312.3K · FY2010–23$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,097,503 · 4
VA$0 · 1
By mechanism
R01$1,552,071 · 1
P20$541,432 · 2
R13$4,000 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Liang Ma$10,259,986
- Walter L Murfee$2,965,430
- Carl A Gregory$3,026,843
Others in their field
Top investigators on “Inflammation”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$89,523,713
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Randall J Bateman · Washington University$64,707,456
- Peter Scott Heeger · Case Western Reserve University$56,547,884
Research focus
InflammationMalignant NeoplasmsKnockout MiceKnock-OutInflammatoryProstateReceptorSpecimenMalignant Neoplasm Of ProstateCytokineMolecularPreventionCancer PatientMutationMediatingCancer EtiologyAnimal ModelSignal TransductionClinically SignificantMutantBaseResponseSignal PathwayProteins
Grant awards (13)
The role of IL-17 in obesity-associated prostate cancer progression$0
I01 · FY2023 · VA · contact PI
The role of IL-17 in obesity-associated prostate cancer progression$0
I01 · FY2022 · VA · contact PI
The role of IL-17 in obesity-associated prostate cancer progression$0
I01 · FY2021 · VA · contact PI
Society for Basic Urologic Research 2019 Annual Meeting "NOVEL DISCOVERIES IN UROLOGY: BIG DATA TO MICROBIOME"$4,000
R13 · FY2020 · CA · contact PI
The role of IL-17 in obesity-associated prostate cancer progression$0
I01 · FY2020 · VA · contact PI
The role of IL-17 in obesity-associated prostate cancer progression$0
I01 · FY2019 · VA · contact PI
The role of IL-17 in prostate cancer$312,288
R01 · FY2017 · CA · contact PI
The role of IL-17 in prostate cancer$312,288
R01 · FY2016 · CA · contact PI
The role of IL-17 in prostate cancer$312,288
R01 · FY2015 · CA · contact PI
The role of IL-17 in prostate cancer$302,919
R01 · FY2014 · CA · contact PI
The role of IL-17 in prostate cancer$312,288
R01 · FY2013 · CA · contact PI
THE ROLE OF CYTOKINE RECEPTOR INTERLEUKIN-17RC IN INITIATION OF PROSTATE CANCER$273,541
P20 · FY2011 · RR · contact PI
THE ROLE OF CYTOKINE RECEPTOR INTERLEUKIN-17RC IN INITIATION OF PROSTATE CANCER$267,891
P20 · FY2010 · RR · contact PI